Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Cell Immunol ; 293(1): 1-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25461611

ABSTRACT

In this study, we demonstrate that G-CSF administration triggers distinct kinetics of stem cell-SC mobilization with early raise of hematopoietic-HSC and late increase of mesenchymal-MSC in bone marrow-BM and peripheral blood-PB. The cytokine microenvironment observed following primary cultures showed an overall G-CSF dose-dependent profile with a clear mixed pro-inflammatory/regulatory pattern. Moreover, primary cultures performed at the peak of MSC/HSC ratio, showed distinct cytokine patterns, with higher IL-10, TNF-α and IL-17A observed for BM and enhanced IL-10, IL-2 and IFN-γ for PB harvested cells. Positive correlation was observed between BM-MSC and the levels of TNF-α, IL-10 and IL-17A whereas negative correlation was found between IL-10 and BM-HSC. An opposite association was observed between IL-10 and PB-HSC. Our results support the hypothesis that MSC and HSC harvested from BM and PB display differential functional properties that should be considered when electing the SC sources available for cell therapy applied in clinical protocols.


Subject(s)
Bone Marrow Cells/drug effects , Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/drug effects , Leukocytes, Mononuclear/drug effects , Mesenchymal Stem Cells/drug effects , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Dose-Response Relationship, Immunologic , Female , Hematopoietic Stem Cell Mobilization , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Immunophenotyping , Interleukin-10/biosynthesis , Interleukin-10/metabolism , Interleukin-17/biosynthesis , Interleukin-17/metabolism , Interleukin-2/biosynthesis , Interleukin-2/metabolism , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/immunology , Mice , Primary Cell Culture , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/metabolism
2.
J Med Virol ; 85(6): 1009-18, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23591975

ABSTRACT

In the past decades patients with hemophilia were infected commonly by hepatitis C virus (HCV) and a significant number of patients are infected chronically. Focusing on the role of the immune system for controlling and or maintaining HCV infection, the leukocyte and cytokine profiles of peripheral blood from hemophilia A patients and other patients with and without HCV infection were studied. The results demonstrated that hemophilia A is characterized by a general state of circulating leukocytes activation along with an overall increase in the frequency of IL-6 and IL-10 with decrease of IL-8 and IL-12. HCV infection of patients with hemophilia A does not influence further the activation state of circulating leukocytes but is accompanied by lower levels of alanine transaminase (ALT) and a prominent anti-inflammatory/regulatory serum cytokine pattern, mediated by IL-4 and IL-10. Additionally, the results demonstrated that hemophilia A patients infected with HCV displaying No/Low antibody response to C33c and C22 have significant lower viral load and higher serum levels of IL-12 and IL-4. This finding suggests that the differential RIBA reactivity to C33c/C22 HCV core proteins may have a putative value as a prognostic biomarker for the infection in hemophilia A patients.


Subject(s)
Antibodies, Viral/blood , Hemophilia A/immunology , Hepacivirus/immunology , Hepatitis C, Chronic/immunology , Interleukin-10/blood , Interleukin-4/blood , Viral Core Proteins/immunology , Adult , Antibodies, Viral/immunology , Cellular Microenvironment/immunology , Female , Hemophilia A/blood , Hemophilia A/complications , Hemophilia A/diagnosis , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/diagnosis , Humans , Immunity, Innate , Interleukin-10/immunology , Interleukin-12/blood , Interleukin-12/immunology , Interleukin-4/immunology , Interleukin-6/blood , Interleukin-6/immunology , Male , Middle Aged , Viral Load
3.
Eur J Dermatol ; 22(4): 488-94, 2012.
Article in English | MEDLINE | ID: mdl-22641009

ABSTRACT

Interleukin-17A (IL-17A) is a proinflamatory cytokine that plays an important role in fighting pathogens at mucosal interfaces, by summoning neutrophils and upregulating cytoplasmatic antimicrobial peptides. So far, the presence of IL-17A in leprosy has not been demonstrated. The expression of IL-17A and related cytokines (IL-6 and IL-23p19) was addressed through RNA extraction and cDNA quantitative amplification in macerated biopsies of active lesions of 48 leprosy patients and 20 fragments of normal skin of individuals. Blood levels of IL-17A, IL-23p19 and IL-6 were determined by ELISA. We found an abrogated mRNA IL-17A response in all biopsies of leprosy patients, as compared with controls. Circulating IL-17A and IL-23p19 were undetectable in both patients and controls, but IL-6 was higher in lepromatous patients. Although at low levels, IL-17A mRNA in lepromatous patients had an inverse linear correlation with bacillary burden. Low expression of IL-17A in patients may be a constitutive genetic feature of leprosy patients or a circumstantial event induced by the local presence of the pathogen, as an escape mechanism.


Subject(s)
Interleukin-17/genetics , Leprosy/genetics , Leprosy/metabolism , RNA, Messenger/biosynthesis , Skin Diseases, Bacterial/genetics , Skin Diseases, Bacterial/metabolism , Adult , Female , Humans , Male
4.
Rev Soc Bras Med Trop ; 44(5): 638-40, 2011 Oct.
Article in Portuguese | MEDLINE | ID: mdl-22031084

ABSTRACT

INTRODUCTION: In the State of Amazonas, data regarding the prevalence of different genotypes of hepatitis C virus remains scarce. METHODS: The genotype of 69 HCV positive patients was determined. An in-house standardized nested-PCR was used to detect HCV RNA. Genotype assignment was based on type-specific motifs on the sequenced amplicons delimited by primers HC11/HC18 from the 5' untranslated region. RESULTS: Of the 69 patients studied, 65.2% were male and 34.8% were female. Genotype 1 showed the greatest prevalence, followed by 3 and 2. CONCLUSIONS: These data suggesting that Manaus is the point of arrival of HCV in the State of Amazonas.


Subject(s)
Hepacivirus/genetics , Hepatitis C, Chronic/virology , RNA, Viral/analysis , Brazil , Female , Genotype , Humans , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction
5.
Rev. Soc. Bras. Med. Trop ; 44(5): 638-640, Sept.-Oct. 2011. tab
Article in Portuguese | LILACS | ID: lil-602911

ABSTRACT

INTRODUÇÃO: No Estado do Amazonas, os dados sobre a prevalência dos genótipos do vírus da hepatite C ainda são escassos. MÉTODOS: Os genótipos do VHC foram determinados em 69 pacientes da Fundação de Medicina Tropical do Amazonas - FMT-AM. O RNA do VHC foi detectado pela técnica de RT-PCR, utilizando-se iniciadores HC11/HC18 para a região 5'não traduzida. RESULTADOS: Dos 69 pacientes, 65,2 por cento era do sexo masculino e 34,8 por cento do feminino. O genótipo 1 foi o mais prevalente, seguidos dos 3 e 2. CONCLUSÕES: Estes dados sugerem que Manaus é uma porta de entrada do vírus VHC no Estado do Amazonas.


INTRODUCTION: In the State of Amazonas, data regarding the prevalence of different genotypes of hepatitis C virus remains scarce. METHODS: The genotype of 69 HCV positive patients was determined. An in-house standardized nested-PCR was used to detect HCV RNA. Genotype assignment was based on type-specific motifs on the sequenced amplicons delimited by primers HC11/HC18 from the 5' untranslated region. RESULTS: Of the 69 patients studied, 65.2 percent were male and 34.8 percent were female. Genotype 1 showed the greatest prevalence, followed by 3 and 2. CONCLUSIONS: These data suggesting that Manaus is the point of arrival of HCV in the State of Amazonas.


Subject(s)
Female , Humans , Male , Middle Aged , Hepacivirus/genetics , Hepatitis C, Chronic/virology , RNA, Viral/analysis , Brazil , Genotype , Reverse Transcriptase Polymerase Chain Reaction
6.
J Ethnopharmacol ; 134(1): 82-8, 2011 Mar 08.
Article in English | MEDLINE | ID: mdl-21130858

ABSTRACT

AIM OF THE STUDY: This study investigated the efficacy of Marsypianthes chamaedrys Vahl (Lamiaceae) inflorescence and leaf extracts in inhibiting the inflammatory and coagulant actions of Bothrops atrox venom. MATERIALS AND METHODS: Marsypianthes chamaedrys, which is used in Brazil as a folk medicine to treat snakebites and local inflammatory reactions, was tested in vitro to determine its ability to block indirect phospholipase A(2) and direct coagulant activities and in vivo to determine its ability to inhibit leukocyte migration and cytokine release. RESULTS: In vitro, Marsypianthes chamaedrys showed antiphospholipase A(2) and anticoagulant activities; the latter activity was also confirmed by prothrombin time (PT) and activated partial thromboplastin time (aPTT) in the absence of venom. Of the extracts used, those obtained from the crushed plant had the greater inhibitory activity in in vitro tests, showing that biological activity is affected by the way extracts are obtained. In vivo, Marsypianthes chamaedrys inhibited leukocyte migration and the release of the proinflammatory cytokines IL-6 and TNF-α without altering the concentration of the anti-inflammatory cytokine IL-10. CONCLUSIONS: As specific antivenoms are not effective in neutralizing the local action of Bothrops venoms, characterization of the anti-inflammatory mechanisms induced by Marsypianthes chamaedrys is of vital importance if the extracts of this plant species are to be used in future as adjuvants in the treatment of snakebites.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Anticoagulants/pharmacology , Crotalid Venoms/toxicity , Lamiaceae/chemistry , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/pharmacokinetics , Bothrops , Coagulants/antagonists & inhibitors , Cytokines/antagonists & inhibitors , In Vitro Techniques , Male , Mice , Peritonitis/complications , Plant Extracts/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...